FDAMA Allows Novel Genetic Tests To Be Regulated As 510(k)s - CDRH

FDA will likely regulate most genetic tests through the premarket notification process and its related controls - including manufacturing, labeling, adverse event reporting and postmarket study controls, according to Center for Devices and Radiological Health officials.